| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/02/2008 | CA2245941C Disposable test strips for determination of blood analytes, and methods and compositions for making same |
| 09/02/2008 | CA2175577C Receptor on the surface of activated t-cells: acts-4 |
| 09/02/2008 | CA2144307C Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides |
| 08/28/2008 | WO2008103966A2 Compositions and methods using toll-like receptors and unc93b |
| 08/28/2008 | WO2008103905A2 Antibodies that specifically bind irta and methods of use |
| 08/28/2008 | WO2008103824A1 Sensitivity-enhanced dot-antibody linked immunogold assay for virus detection |
| 08/28/2008 | WO2008103815A2 Clinical intervention directed diagnostic methods |
| 08/28/2008 | WO2008103812A1 Compositions and methods for diagnosing and treating endometriosis |
| 08/28/2008 | WO2008103786A1 Multi-strip western blotting procedure to increase quantitative data output |
| 08/28/2008 | WO2008103645A2 Prostate cancer and melanoma antigens |
| 08/28/2008 | WO2008103489A2 Rna targeting compounds and methods for making and using same |
| 08/28/2008 | WO2008103393A1 Protein trafficking |
| 08/28/2008 | WO2008103327A2 Mn/ca ix and bladder cancer |
| 08/28/2008 | WO2008103319A2 Compounds and methods for use in detecting gabapentin |
| 08/28/2008 | WO2008103292A1 Method of identifying risk for thyroid disorder |
| 08/28/2008 | WO2008103202A2 Hypoxia related genes and proteins for the treatment and diagnosis of pregnancy related complications |
| 08/28/2008 | WO2008103178A1 Forensic test for human semen |
| 08/28/2008 | WO2008103028A1 Method of determining the toxicity of a sample flow, and apparatus therefor |
| 08/28/2008 | WO2008102912A1 Target protein and target gene for drug discovery, and screening method |
| 08/28/2008 | WO2008102906A1 Hspc-hrpc transition genes |
| 08/28/2008 | WO2008102870A1 Pyridine or pyrimidine derivative having excellent cell growth inhibition effect and excellent anti-tumor effect on cell strain having amplification of hgfr gene |
| 08/28/2008 | WO2008102833A1 Kit for immunoassay of bsh, and method for measurement of bsh |
| 08/28/2008 | WO2008102777A1 Ameliorating agent for insulin resistance |
| 08/28/2008 | WO2008102744A1 Method for production of molded resin article |
| 08/28/2008 | WO2008102606A1 Method of detecting amplification or deletion in genomic dna fragment |
| 08/28/2008 | WO2008102557A1 Peptide vaccines for cancers expressing tumor-associated antigens |
| 08/28/2008 | WO2008102299A1 Magnetic sensor device with field generator and sensor element |
| 08/28/2008 | WO2008102218A1 A sensor device for and a method of sensing magnetic particles |
| 08/28/2008 | WO2008102149A1 Holographic sensors |
| 08/28/2008 | WO2008102148A1 Method and apparatus for handling food pieces |
| 08/28/2008 | WO2008102143A1 Quality control of meat products and the like |
| 08/28/2008 | WO2008102121A1 Formation of lipid bilayers |
| 08/28/2008 | WO2008102120A1 Lipid bilayer sensor system |
| 08/28/2008 | WO2008102000A1 Human pancreatic beta cell lines for diagnostic of diabetes |
| 08/28/2008 | WO2008101736A1 Mass spectrometric quantitative detection of methyl malonic acid and succinic acid using hilic on a zwitterionic stationary phase |
| 08/28/2008 | WO2008101478A1 Ozone sensor having a hydrothermal buffer |
| 08/28/2008 | WO2008101311A1 Process for purification of water soluble polymers |
| 08/28/2008 | WO2008101298A1 Brewing apparatus and method |
| 08/28/2008 | WO2008081470B1 Electronic level sensor and timer based falling head soil permeameter |
| 08/28/2008 | WO2008080218A9 Methods of selecting and producing modified toxins, conjugates containing modified toxins and uses thereof |
| 08/28/2008 | WO2008075194A3 Assay device and method |
| 08/28/2008 | WO2008073635A3 Automatable artificial immune system (ais) |
| 08/28/2008 | WO2008073042A9 Continuously repeatable method of detecting antigens in test volume |
| 08/28/2008 | WO2008072156A3 Microelectronic sensor device for detecting label particles |
| 08/28/2008 | WO2008070676A3 Multiplex assay reader system |
| 08/28/2008 | WO2008067091A3 Assay membrane and method of use thereof |
| 08/28/2008 | WO2008067055A3 Stable acridinium esters with fast light emission |
| 08/28/2008 | WO2008065324A8 System and method for qualitative and quantitative analysis of gaseous components of multiphase hydrocarbon mixtures |
| 08/28/2008 | WO2008061214A3 Gas sensor with an analyte modulator |
| 08/28/2008 | WO2008061073A3 Hematology linearity control composition system and method of use |
| 08/28/2008 | WO2008061019A3 Modulators of neuronal regeneration |
| 08/28/2008 | WO2008060702A9 Replikin peptides and uses thereof |
| 08/28/2008 | WO2008060651A3 Sparc and methods of use thereof |
| 08/28/2008 | WO2008052057A3 Method and system for providing analyte monitoring |
| 08/28/2008 | WO2008049209B1 Endophyte enhanced seedlings with increased pest tolerance |
| 08/28/2008 | WO2008047364A3 Method and pharmacological composition for the diagnosis and treatment of male sub-fertility |
| 08/28/2008 | WO2008043461A3 Inhibition of pde2a |
| 08/28/2008 | WO2008042018A3 Nanopore platforms for ion channel recordings and single molecule detection and analysis |
| 08/28/2008 | WO2008036419A3 Aldehyde dehydrogenase 1(aldh1) as a cancer stem cell marker |
| 08/28/2008 | WO2008035073A3 Method of detecting interactions on a microarray using nuclear magnetic resonance |
| 08/28/2008 | WO2008032205A3 Nucleic acid detection using flow through methods |
| 08/28/2008 | WO2008030735A3 Biomarkers for assessing response to c-met treatment |
| 08/28/2008 | WO2008030273A3 Compositions and methods for diagnosis and treatment of type 2 diabetes |
| 08/28/2008 | WO2008030115A3 Fluorescent cell markers |
| 08/28/2008 | WO2008027075A3 Sulfhydryl-reactive, water soluble dyes |
| 08/28/2008 | WO2008024496A3 Analytic plates with markable portions and methods of use |
| 08/28/2008 | WO2008019060A3 Method for predicting onset/risk of atrial fibrillation (af) |
| 08/28/2008 | WO2008012642A3 Process for determining s-nitrosothiols in biological fluids |
| 08/28/2008 | WO2008010980A3 Tat-049 and methods of assessing and treating cancer |
| 08/28/2008 | WO2008010093A3 Meganuclease variants cleaving a dna target sequence from a rag gene and uses thereof |
| 08/28/2008 | WO2008002267A8 A sensor kit and a system for detecting an analyte in a test environment |
| 08/28/2008 | WO2007123880A3 Methods and kits for early stage caries detection |
| 08/28/2008 | WO2007123682A3 Detection of membrane androgen receptor (mar) agents |
| 08/28/2008 | WO2007062719A3 Detection unit, in particular biosensor, and use thereof |
| 08/28/2008 | WO2006084272A3 Methods of predicting chemotherapy responsiveness in breast cancer patients |
| 08/28/2008 | US20080209580 Mouse developing visceral fat type obesity and diabetes |
| 08/28/2008 | US20080208484 Apparatus and method for air-in-line detection |
| 08/28/2008 | US20080208482 Display Producing System |
| 08/28/2008 | US20080208481 Automatic analyzer |
| 08/28/2008 | US20080208479 Devices and Methods for Calculating and Communicating Differences in Measured Data |
| 08/28/2008 | US20080208081 System and Method For Determining Tibial Rotation |
| 08/28/2008 | US20080207895 Methods for synthesizing polysaccharides |
| 08/28/2008 | US20080207877 Granulocyte cell stimulating factor (G-CSF), erythropoietin, interferon, and growth hormone |
| 08/28/2008 | US20080207714 Diagnosis And Treatment Of Breast Cancer |
| 08/28/2008 | US20080207615 Using allelic variations in epidermal growth factor gene as evaluative tool in predicting positive response to anticancer agents, therapy; administering gefitinib |
| 08/28/2008 | US20080207604 Dtection compound that moderated tau-tau protein association; Alzheimer's disease; administering methylene blue |
| 08/28/2008 | US20080207574 Withanolides, probes and binding targets and methods of use thereof |
| 08/28/2008 | US20080207557 A time-release formulation of a water-soluble derivative having the fatty acid moiety removed and an antiinflammatory agent; opoid resistant neuropathic pain, amputation pain or neuralgia; |
| 08/28/2008 | US20080207540 Use of LRH-1 response elements derived from the apolipoprotein A1 gene promoter, cells, vectors and genetic constructs to increase HDL levels; atherosclerosis |
| 08/28/2008 | US20080207518 Peptide analog with substitutions useful for therapy and prophylaxis of diseases and disorders related to ACTH, ACTH receptors or corticosteroid secretion, such as premature labor and Cushing's Disease; veterinary medicine, agriculture, aquaculture |
| 08/28/2008 | US20080207509 Scaffold |
| 08/28/2008 | US20080207506 Nucleic acid sequence coding Mammastatin; protein useful in diagnosis, therapy fo breast cancer ; antigrowth agents |
| 08/28/2008 | US20080207504 SECRETED FRIZZLED RELATED PROTEIN, sFRP, FRAGMENTS AND METHODS OF USE THEREOF |
| 08/28/2008 | US20080207488 Removal of conformational altered protein; side effect reduction |
| 08/28/2008 | US20080207485 Major histocompatibility complex with peptide binding grooves; controlling oligomerization |
| 08/28/2008 | US20080207449 Polypeptides; antisense nucleic acids; gene expression vectors that have been inserted: transgenic plants; agriculture; diagnosis; screening; therapy |
| 08/28/2008 | US20080206894 Bioresponsive Hydrogels |
| 08/28/2008 | US20080206893 Biosensor and Method |
| 08/28/2008 | US20080206892 Rapid Magnetic Biosensor With Integrated Arrival Time Measuremnt |
| 08/28/2008 | US20080206891 Synthetic antiferromagnetic nanoparticles |